Moreover, CML patients’ serum displayed enhanced levels of several angiogenic factors including vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) [134]. This evidence concerns the gene VEGFA and chronic myelogenous leukemia, BCR-ABL1 positive.